425508009: sitagliptine phosphate (substance)

SNOMED CT Concept\substance\...

\Substance categorized by disposition\Substance with effector mechanism of action (substance)\Enzyme inhibitor\inhibiteur d'hydrolase\inhibiteur de l'hydrolase peptidique\...

\Proteinase inhibitor\Serine proteinase inhibitor\sitagliptine phosphate

\Dipeptidyl peptidase IV inhibitor\sitagliptine phosphate

\substance catégorisée selon sa structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\sitagliptine phosphate

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Substance with triazole structure (substance)\sitagliptine phosphate
\Organic compound\Organic nitrogen compound\Azole\Substance with triazole structure (substance)\sitagliptine phosphate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
sitagliptine phosphate	est un(e) (attribut)	Serine proteinase inhibitor	true	Inferred relationship	Some
sitagliptine phosphate	Has disposition (attribute)	Serine proteinase inhibitor (disposition)	true	Inferred relationship	Some
sitagliptine phosphate	est un(e) (attribut)	Substance with triazole structure (substance)	true	Inferred relationship	Some
sitagliptine phosphate	est un(e) (attribut)	Sitagliptin (substance)	false	Inferred relationship	Some
sitagliptine phosphate	Has disposition (attribute)	Dipeptidyl peptidase IV inhibitor (disposition)	true	Inferred relationship	Some
sitagliptine phosphate	Is modification of (attribute)	Sitagliptin (substance)	true	Inferred relationship	Some
sitagliptine phosphate	est un(e) (attribut)	Dipeptidyl peptidase IV inhibitor	true	Inferred relationship	Some
sitagliptine phosphate	est un(e) (attribut)	Triazole derivative (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Sitagliptin phosphate monohydrate (substance)	Is modification of (attribute)	True	sitagliptine phosphate	Inferred relationship	Some
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	sitagliptine phosphate	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet	Has precise active ingredient	True	sitagliptine phosphate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	sitagliptine phosphate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	sitagliptine phosphate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some
Product containing metformin and sitagliptin (medicinal product)	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some	1
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some	1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug)	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	sitagliptine phosphate	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet	a pour principe actif (attribut)	False	sitagliptine phosphate	Inferred relationship	Some	2
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet	Has basis of strength substance (attribute)	False	sitagliptine phosphate	Inferred relationship	Some	2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	False	sitagliptine phosphate	Inferred relationship	Some	1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	True	sitagliptine phosphate	Inferred relationship	Some	1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet (clinical drug)	Has precise active ingredient	False	sitagliptine phosphate	Inferred relationship	Some	1
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet	Has precise active ingredient	True	sitagliptine phosphate	Inferred relationship	Some	1
Metformin hydrochloride 500 mg and sitagliptin phosphate 50 mg oral tablet	Has precise active ingredient	False	sitagliptine phosphate	Inferred relationship	Some	2
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet	Has precise active ingredient	True	sitagliptine phosphate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
19261000188113	sitagliptine phosphate	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)
2661573010	Sitagliptin phosphate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2675154010	Sitagliptin phosphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
665491000241119	sitagliptine phosphate (substance)	fr	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Common French translation module (core metadata concept)